MAp: Changing strokes
With the ink barely dry on its corporate simplification, MAp Group announced bold new plans for Sydney Airport.
Franklins boost for Metcash
The past six months were difficult but with Franklins under its umbrella, profit growth is likely to resume.
Cheers to Foster's
With a more than 30% return since our original recommendation less than two years ago, the acquisition of Foster’s delivers a great result. But spend the money wisely.
F&P Healthcare's headwind
It was a very respectable interim result but shareholders have little to show for it. Nathan Bell makes the case for hanging on.
Downdraught prompts Infigen upgrade
Despite rumours of ‘corporate action’, Infigen’s share price is back in the bargain bin. Gareth Brown makes the case for an upgrade.
Woolies goes Dutch
Woolworths has broken with management tradition by hiring outside. It’s something to watch, not worry about.
Origin Notes next in pipeline
The latest income security offers a high rate of return in exchange for a few risks buried in the small print.
Trade Me not
Trade Me is an impressive business. But now isn’t the time to buy, especially not with Fairfax as a controlling shareholder. Nathan Bell explains.
BHP Billiton's new gambit
BHP has already made big bets on China and India. Now it’s placing another one, on America.
AFIC notes on fire
This convertible note offer has the safety features of a bond, an interest rate to match and a free lotto ticket. No wonder it's popular.
Silver Lake: Profits and prophecy
Knowing when to take profits is as important as buying in the first place. Gaurav Sodhi examines the options in this soaring gold stock.
Slowly begins the gas boom
Gas prices are set to rise on the east coast, with positive knock-on effects for two of our current buy recommendations.
MAp clears the runway
A fresh focus on Sydney Airport is great for owners. We recommend you vote in favour of all resolutions at the forthcoming meeting.
Flight Centre: Shops v Internet
On a forecast PER of 10 (and perhaps lower), this stock looks cheap. But there are two very good reasons why you shouldn’t buy it.
Platinum hopes for dollar dive
The strong dollar hasn’t helped Platinum’s funds. But better times lie ahead, James Greenhalgh reports.
Call 1300 880 160
Start a chat
Schedule a call
